Table 5.

Cytology/hrHPV sensitivity in VaIN patients after hysterectomy and with no hysterectomy.

VaIN	No hysterectomy	After hysterectomy	P value
Cytology sensitivity
VaIN	59.5% (194/326)	69.6% (55/79)	0.098
VaIN1	59.6% (174/292)	64.2% (34/53)	0.532
VaIN2/3	58.8% (20/34)	80.8% (21/26)	0.070
hrHPV sensitivity
VaIN	86.5% (239/276)	90.4% (66/73)	0.382
VaIN1	85.7% (210/245)	89.4% (42/47)	0.505
VaIN2/3	93.5% (29/31)	92.3% (24/26)	0.855
Cotesting sensitivity
VaIN	91.9% (239/260)	98.5% (65/66)	0.058
VaIN1	91.9% (216/235)	97.7% (43/44)	0.170
VaIN2/3	92.0% (23/25)	100.0% (22/22)	0.175

VaIN: vaginal intraepithelial neoplasia; hrHPV: high-risk human papillomavirus.